Logo
    Search

    Podcast Summary

    • A call for ECT ban based on outdated data challengedRecent studies show ECT's benefits, particularly as an adjunctive treatment for conditions like schizophrenia and catatonia, despite ongoing debate and calls for ban based on older data.

      The debate surrounding Electroconvulsive Therapy (ECT) continues, with some criticizing its safety and effectiveness based on older data. However, numerous observational studies conducted since the introduction of ECT in the late 1930s have shown its benefits, particularly as an adjunctive treatment for conditions like schizophrenia and catatonia. A recent editorial by doctors Michael Cummings and Jennifer O'Day, published in CNS Spectrums, strongly objected to a call for ECT to be banned in the UK based on outdated data and a narrow focus on major depression. The editorial cited several studies, including one that found a strong effect size favoring ECT with clozapine in treatment-resistant schizophrenia. Depriving patients of this treatment, which is often a last resort for those with few viable alternatives, would be detrimental. The editorial also addressed concerns about women being unfairly targeted in the use of ECT, which were not mentioned in the article sent to doctor Cummings. Overall, the ongoing discussion highlights the importance of considering the vast body of evidence supporting ECT and its role in mental health treatment.

    • ECT: A Valuable Treatment Option for Major DepressionECT is a valuable treatment for major depression, particularly for women, and does not cause permanent brain damage or memory loss. It can be life-transforming for some patients with treatment-resistant depression, severe melancholia, catatonia, or schizophrenia, with memory function usually recovering once depression improves.

      Electroconvulsive Therapy (ECT) is a valuable treatment option for major depression, particularly for women, and it does not cause permanent brain damage or memory loss. Contrary to common misconceptions, studies have not found any evidence of structural brain damage from ECT. For some patients, including those with treatment-resistant depression, severe melancholia, catatonia, or schizophrenia, ECT can be a life-transforming procedure. Although there may be temporary memory issues during the treatment, anterograde memory remains intact, and memory function usually recovers once the depression improves. Additionally, severe mental illnesses like depression, catatonia, and schizophrenia can cause cognitive and memory impairment themselves. It's essential to recognize the importance and effectiveness of ECT for those who need it, despite the misconceptions and misrepresentations that exist.

    • Mental health conditions can lead to brain damage and cognitive impairment if left untreatedMental health conditions like depression, bipolar, and schizophrenia can cause brain damage, leading to impaired cognitive function and personality changes if left untreated. ECT, a psychiatric treatment, is effective for those who haven't responded to antidepressants, despite some criticisms.

      Major mental health conditions like depression, bipolar, and schizophrenia can cause significant damage to the brain, leading to impaired cognitive function, memory loss, and personality changes if left untreated. This damage is evident even in severe cases where patients have gone without proper care for extended periods. The consequences of this neglect are tragic, as these individuals often suffer needlessly. When encountering criticisms against psychiatry and its treatments, it's essential to consider whether the critics have experience working directly with the patient population in question. In the case of Electroconvulsive Therapy (ECT), early studies comparing placebo ECT to actual ECT treatments showed substantial differences in outcomes. For instance, the Nottingham ECT study reported an MADRS score decrease of 8.7 for the simulated ECT group, while unilateral ECT and bilateral ECT groups showed decreases of 24 and 24.7, respectively. ECT is not a perfect treatment, but it is highly effective, particularly for those who have not responded to antidepressants. The recurrence of mental illness after ECT treatment is not a valid criticism, as most patients continue receiving additional care, such as antidepressants, to maintain their progress.

    • Effective long-term treatment for major depression with antidepressant resistanceECT directly alters DNA transcription, improving neuronal function for individuals with recurring major depression, but not suitable for everyone

      For individuals with major depression who do not respond adequately to antidepressant medications, maintenance Electroconvulsive Therapy (ECT) can be an effective long-term treatment option. ECT works by directly altering DNA transcription in neurons, turning on genes responsible for producing growth factors and improving neuronal function. Maintenance ECT is particularly beneficial for individuals with recurring major depression, as their depression tends to become more resistant to pharmacotherapy over time. However, it's important to note that not everyone is a good candidate for ECT. Those heavily medicated or with a history of borderline personality disorder or neurotic conditions may not respond well to this treatment. ECT is more effective and faster acting than antidepressant medications, with many people experiencing noticeable improvements after just a few treatments.

    • Understanding ECT: A Misunderstood Treatment for Severe Mental IllnessECT is a safe, effective treatment for severe mental illness, but it's often misunderstood due to outdated portrayals and limited access. Modern ECT is painless, with anesthesia and paralysis used to ensure safety.

      Electroconvulsive Therapy (ECT) is an effective treatment option, particularly in severe cases of mental illness such as neuroleptic malignant syndrome, severe catatonia, or melancholic depression where the person's life is at risk. However, it should not be the first treatment choice and is not frequently used due to its acuity and severity level. The stigma surrounding ECT is largely due to misconceptions, such as the outdated portrayal of unmodified ECT in movies like "One Flew Over the Cuckoo's Nest." Modern ECT is safe and painless, with the person being put to sleep with anesthesia and paralyzed during the procedure. The amount of electricity given is just enough to cause a seizure, and the debate continues over whether it's the seizure or the immediate postictal period that triggers the therapeutic response. Despite its effectiveness, access to ECT can be limited in certain settings, such as the prison system. It's important to recognize the importance of ECT in the medical system and to promote accurate information about the procedure to reduce stigma.

    • Exploring the potential of Ketamine and ECT for depression treatmentKetamine offers rapid antidepressant effects but limited duration, while ECT has a higher response rate but more sessions and risks. Combining the two may provide synergistic benefits, but more research is needed.

      Ketamine and Electroconvulsive Therapy (ECT) are two distinct but potentially complementary treatments for depression. Ketamine, an antidepressant with dissociative properties, can produce rapid antidepressant responses, but its effects are time-limited and may diminish with repeated treatments. ECT, on the other hand, has a higher response rate but requires more sessions and carries risks related to anesthesia. A recent study suggested that Ketamine may be a viable alternative to ECT for some patients, especially those who prefer not to undergo ECT or need a rapid response. However, more research is needed to understand the potential synergistic effects of combining the two modalities. Regarding safety considerations, medications like lithium should be carefully managed before ECT due to its potential interaction with succinylcholine and postictal confusion. Additionally, patients with certain medical conditions, such as bradyarrhythmias, unstable hypertension, or severe cardiac illness, may require special attention during ECT treatment. Catatonia, a neurological and psychiatric condition characterized by motor and cognitive impairments, can be treated with ECT, which can help restore normal brain function and improve symptoms.

    • Identifying and Treating Catatonia: A Complex ConditionCatatonia, a complication of major depression and schizophrenia, can present as immobility or excessive motor activity. The Bush Francis Catatonia Rating Scale helps diagnose and quantify symptoms. Benzodiazepines are first-line treatment, but not all respond. ECT may be necessary. Catatonia is often underdiagnosed; correct use of Benzodiazepines is crucial.

      Catatonia, a condition characterized by motor and behavioral abnormalities, can be a complication of various underlying illnesses such as major depression and schizophrenia. It can present as catatonic stupor, where the person is immobile and unresponsive, or excited catatonia, where the person is excessively motoric. The Bush Francis Catatonia Rating Scale is a useful tool for identifying and quantifying catatonic features. Echolalia and echopraxia, common symptoms, involve the repetition of speech or movements, respectively. Benzodiazepines, such as Ativan, are often the first line of treatment, but not all cases respond. ECT may be necessary for those who do not respond to Benzodiazepines. It's important to note that catatonia is often underdiagnosed, and a higher index of suspicion is needed. Incorrect use of Benzodiazepines, such as insufficient dosing or discontinuation too soon, can worsen the situation. The typical dose range for lorazazepam in catatonia is 6 to 9 milligrams a day, and intramuscular administration may be more effective. A definitive lorazepam challenge requires a rapid rise in blood levels, which may not occur with oral administration.

    • Collaboration between doctors and nursing staff for optimal patient careNursing staff observations can lead to earlier diagnosis and intervention, improving patient outcomes. Collaboration between doctors and nursing staff is crucial. ECT can be an effective treatment for treatment-resistant symptoms in schizophrenia patients.

      Effective communication and collaboration between members of a healthcare team are crucial for providing optimal patient care. During a discussion about catatonia, it was emphasized that nursing staff, who spend more time with patients than doctors, may observe critical signs that doctors may miss. In such cases, nursing staff should not hesitate to share their observations with doctors, especially when the severity and necessity for treatment warrant it. This collaboration can lead to earlier diagnosis and intervention, ultimately improving patient outcomes. Another key point was that Electroconvulsive Therapy (ECT) can be an effective treatment option for individuals with schizophrenia who have treatment-resistant symptoms and have not responded well to clozapine. This information highlights the importance of a multidisciplinary approach in mental health care and the value of each team member's unique perspective and expertise.

    • Effective treatment for severe bipolar depression and unresponsive manic statesECT is a safe and effective treatment for severe bipolar depression, mixed mood states, and unresponsive manic states, as well as for pregnant women and those with factitious disorders who refuse medications. It's also used for depression in Parkinson's disease. Discuss the pros and cons with a healthcare provider before deciding to undergo ECT.

      Electroconvulsive Therapy (ECT) can be an effective treatment option when other medications, such as antipsychotics and mood stabilizers, have not worked for individuals with severe bipolar depression, mixed mood states, or unresponsive manic states. ECT is also a safe alternative for pregnant women who cannot or will not take medications, and for those with factitious disorders who refuse medications. ECT is also used in certain cases of Parkinson's disease with depression. The safety record of ECT is impressive, with a very low mortality rate. Patients considering ECT should educate themselves about the treatment and discuss the pros and cons with their healthcare provider. For healthcare professionals, attending a brief certification fellowship in ECT is a worthwhile investment. ECT is not without risks, but its benefits often outweigh those risks for individuals with certain mental health conditions.

    • Understanding the Expertise Behind Electroconvulsive TherapyECT certification focuses on technical aspects, mental health professionals should be aware of experts, important tool for severe conditions, life-saving intervention, extensive expertise required

      While ECT certification programs may only last a few weeks, the individuals undergoing this training have already accumulated thousands of hours of patient care and diagnosis experience beforehand. The certification primarily focuses on the technical aspects of providing Electroconvulsive Therapy (ECT). As mental health professionals, it's essential to be aware of ECT and the experts in our community who provide it. It's an important tool in our collective toolbox, especially for patients with severe conditions that do not respond to other treatments like psychotherapy. ECT can be a life-saving intervention for some individuals, and it's crucial to have a good understanding of its applications and benefits. In summary, while the technical training for ECT may be brief, the overall expertise and experience required to effectively administer this treatment are extensive.

    Recent Episodes from Psychiatry & Psychotherapy Podcast

    Reflective Functioning: The Key to Attachment with Dr. Howard Steele

    Reflective Functioning: The Key to Attachment with Dr. Howard Steele

    In this episode, we discuss “reflective function,” which is a precursor to the concept of mentalization. Reflective function is best understood not as synonymous with mentalization, but as a scale from -1 to 9, based off certain adult attachment interview questions that measure the person’s ability to describe their own and others’ internal states, motivations, and articulate a nuanced and unique understanding of life from 0 to 12 years old. This scale was developed by attachment researchers at the University of London, including Dr. Howard Steele and Dr. Peter Fonagy.

    Bruce Perry on the Healing Power of Human Connection and Resilience in Trauma

    Bruce Perry on the Healing Power of Human Connection and Resilience in Trauma

    In today’s episode, we talk with Dr. Bruce Perry who co-authored, The Boy Who Was Raised As A Dog, Born For Love: Why Empathy is Essential and Endangered, and What Happened to You? Conversations on Trauma, Resilience, and Healing (2021). We are also joined by Megan White Zappitelli, M.D., a child and adolescent psychiatrist, and Maddison Hussey, M.D., a child and adolescent fellow. 

    Early Psychosis: Detection and Treatment

    Early Psychosis: Detection and Treatment

    In this episode, we are joined by a panel of experts to discuss treatment of psychosis. Experiences of psychosis are common. When these experiences lead to interference in achieving life goals and/or distress, individuals can benefit from seeking evidenced-based care. The earlier individuals experiencing psychosis come to treatment, the better the outcomes. We are all allies in connecting these young people to care and services. Recovery is possible—people living with psychosis experiences can lead full, meaningful, and fulfilling lives. 

    Q&A with Dr. Michael Cummings

    Q&A with Dr. Michael Cummings

    In this episode, we welcome back fan favorite Dr. Michael Cummings and ask questions sent in by listeners. Topics include Schizophrenia, Social Media Trends, and the SSRI controversy. We are thrilled to dedicate an episode that allows individuals to ask pointed questions and glean from Dr. Cummings' expertise. 

    What People Want From Therapy with Linda Michaels

    What People Want From Therapy with Linda Michaels

    Therapies of depth, insight, and relationship have been missing from, if not pushed out of, the public conversation on mental health treatment. After decades of attack from multiple fronts, these therapies are misunderstood, undervalued, and overlooked by the general public. In order to address this challenge and change this trajectory, we must start by listening to the public and understand their needs, values, and preferences about therapy. Dr. Linda Michaels and colleagues conducted an extensive research project, leveraging qualitative and quantitative tools and techniques widely used in the corporate world, focused on “listening” to the public and understanding what people want and need from therapy. 

    Linda Michaels, PsyD, MBA, is a clinical psychologist in private practice in Chicago. She is also chair and co-founder of the Psychotherapy Action Network (PsiAN), a non-profit that advocates for quality therapy. 

    Link to blog here.

    5 Factors and Domains of Psychiatric Care

    5 Factors and Domains of Psychiatric Care

    In this Episode, Dr. David Puder, Dr. Adam Borecky, and Joanie Burns discuss the 5-factor approach to holistic, patient-centered psychiatric care. This approach takes into account that each individual who seeks care is unique in their physiological and psychological make-up and that multiple factors influence both physical and mental health (for better or worse). 

    The 5-factor approach to treatment is based on the importance of sensorium and its pivotal role in regulating thoughts, feelings, and overall mental health. Sensorium is a lens to understand how we focus on various things. Sensorium is total brain function, which fluctuates throughout the day and depends on a number of factors, including sleep, stress levels, and more.

    Mentalization Based Therapy (MBT), with Dr. Anthony W. Bateman, MA, FRCPSYCH and Dr. Peter Fonagy, Ph.D., FBA

    Mentalization Based Therapy (MBT), with Dr. Anthony W. Bateman, MA, FRCPSYCH and Dr. Peter Fonagy, Ph.D., FBA

    In this episode, we are joined by Dr. Anthony W. Bateman and Dr. Peter Fonagy to discuss their expertise on Mentalization. 

    Mentalization refers to the capacity to reflect upon and understand one's own state of mind and the states of mind of others.  This involves recognizing and making sense of one's own and others’ emotions, beliefs, needs and desires.  People use this tool consciously and unconsciously to make sense of others and themselves. Often done automatically, a person may form beliefs about the people they interact with, making assumptions about their mental states. These beliefs tend to have a strong influence on the mental state of the person, whether or not they are correct.

     

    Beginning the Treatment with Jonathan Shedler, PhD

    Beginning the Treatment with Jonathan Shedler, PhD

    Dr. Jonathan Shedler is well known for his work on the efficacy of psychodynamic therapy. He has highlighted the importance of the initial phase of therapy in establishing a foundation for successful treatment. Dr. Shedler strongly believes the consultation phase is crucial to developing a working alliance between client and therapist and building a treatment frame and structure. Without this foundation, there is no mutual understanding about the goal or the purpose of treatment, and psychotherapy should not move forward. Join us in this episode as Dr. Shelder discusses how to create a firm starting foundation in clinical practice.

    Adverse Childhood Experiences Part 2: Measurement, Impact on Future Mental Health, Dissociation, and Timing of Trauma

    Adverse Childhood Experiences Part 2: Measurement, Impact on Future Mental Health, Dissociation, and Timing of Trauma

    In this week’s episode of the podcast, we will continue our discussion regarding adverse childhood experiences (ACEs) and their influence on the development of future mental health disorders. The greatest predictive factor of the relationship between ACEs and future mental health disorders has to do with the severity, duration, and number of traumatic events. We’ll explore the Childhood Trauma Questionnaire and the data of how ACEs increase the risk of certain personality disorders and psychiatric conditions.

    Link to blog: 

    https://www.psychiatrypodcast.com/psychiatry-psychotherapy-podcast/episode-204-adverse-childhood-experiences-part-2-measurement-impact-on-future-mental-health-dissociation-and-timing-of-trauma

    Related Episodes

    How to Manage Aggression with Psychopharmacology in an Inpatient Setting

    How to Manage Aggression with Psychopharmacology in an Inpatient Setting

    Violence and aggression are often used interchangeably, with subtle distinctions differentiating the two. Aggression is an umbrella term that encompasses violence and is defined as actions that lead to harm towards self, others, or objects, while violence is defined as actions that lead to harm, specifically toward other individuals (Newman, 2012). Aggression, according to the 3-factor approach initially detailed by investigators from the New York State Hospital system, is categorized into three types of assault: impulsive, predatory/organized, and psychotic. Impulsive aggression was the most common type at 54%, with predatory/organized type (29%) and psychotic type (17%) trailing behind (Quanbeck CD, 2007; Meyer et al., 2016). This episode aims to explore the management of agitation, aggression, and violence in the inpatient setting.

     

    Link to blog here

    Link to webinars here

    Long-Acting Injectables with Dr. Cummings

    Long-Acting Injectables with Dr. Cummings

    In today’s episode of the podcast, Dr. Michael Cummings returns to discuss the use of long-acting injectable (LAI) antipsychotics. LAIs are administered in intervals ranging from every 2 weeks to every 6 months, eliminating the need for daily oral antipsychotics and thereby improving adherence.

     

    Link to blog here.

    Psychotic Depression with Dr. Cummings

    Psychotic Depression with Dr. Cummings

    The underreporting of psychotic symptoms by patients in depression is a significant concern, frequently driven by the fear of consequences like hospitalization or the stigma of embarrassment. 

     

    We'll discuss the history, the differential to consider when thinking of psychotic depression, mechanisms, and treatment. Notably, individuals with psychotic depression face a suicide rate double that of their non-psychotic counterparts. A recent cohort study by Paljärvi in 2023 revealed a stark contrast: deaths due to suicide were 2.6% in the psychotic depression cohort, compared to 1% in the non-psychotic group. Alarmingly, most suicides occurred within the first two years following diagnosis. People who suffer from psychotic depression often do not report their psychotic symptoms, leading to inadequate response to normal depression treatments. With 6-25% of individuals with major depressive disorder (MDD) exhibiting psychotic features, it is imperative to understand and address these unique challenges. Join us as we unravel the complexities of this underrecognized aspect of mental health.

    Opioid Use Disorder with Dr. Cummings

    Opioid Use Disorder with Dr. Cummings

    This week’s episode is on opioid use disorder and is the second in our series on addiction. We are once again joined by Dr. Michael Cummings.  Dr. Puder and Dr. Cummings discuss the history of opioids, the neurobiology of addiction, risk factors for opioid use disorder, and treatment options.

     

    Link to blog here.

    Obsessive-compulsive Personality and the Personality Continuum with Dr. Shedler

    Obsessive-compulsive Personality and the Personality Continuum with Dr. Shedler

    For over a century, psychoanalytic psychology has recognized certain types of personality configurations that we see repeatedly. A clinician who understands these familiar patterns has a map of the patient’s interior terrain to help navigate treatment. In today’s episode of the podcast, we are joined by Dr. Jonathan Shedler to discuss obsessive-compulsive personality and the continuum on which personalities operate.

    Link to blog here.